Ensysce Biosciences (ENSC)

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

的Ensysce Biosciences, Inc. Common Stock（ENSC）股票的价格今天是$0.58，自市场开启。该公司市值为$210.67万，日交易量为$2.83亿股。对于关注价格走势的投资者来说，Ensysce Biosciences, Inc. Common Stock股票今日的波动区间在$0.57和$0.77之间。前一交易日收盘价为 $0.39。

您准备好开始了吗？按照以下步骤操作，或阅读我们关于在Kraken上从10美元起购买Ensysce Biosciences股票的指南。